Tim Lahm, MD, ATSF

Dr. Tim Lahm is fellowship-trained pulmonologist and researcher who treats lung diseases such as pulmonary hypertension and lymphangioleiomyomatosis.

Special Interests

Dr. Lahm is a physician scientist in the Division of Pulmonary, Critical Care and Sleep Medicine with a focus on the study of sexual dimorphisms in lung vascular remodeling and right ventricular (RV) adaptation in pulmonary hypertension (PH). The overall goal of his research is to identify novel therapeutic interventions for PH-induced RV and lung vascular dysfunction. In particular, he is interested in gender differences in PH and the role of sex hormones in PH and RV failure. His laboratory is studying mechanisms of how sex hormones such as 17β-estradiol affect lung and RV endothelial cell homeostasis as well as cardiomyocyte function during PH and RV failure development. A specific focus is on deciphering how estrogen receptor alpha promotes resilience to maladaptive RV remodeling by regulating angiogenesis, contractile signaling and inflammatory processes.

Other areas of interest in the Lahm lab include studies of hypoxia-induced lung vascular and RV remodeling in the perinatal period and throughout the lifespan, neurohormonal signaling in the RV, exercise effects on RV function, and novel PH phenotypes in the veteran population. The Lahm lab recently expanded its studies of sexually dimorphic lung diseases to study androgen signaling in asthma and to identify mechanisms of how androgens modulate airway epithelial cell function.

Dr. Lahm’s clinical interest is in PH, RV failure and lymphangioleiomyomatosis - conditions that exhibit significant gender biases and that disproportionally affect women. He is also passionate about critical care medicine and provides care to critically ill patients in the intensive care unit.

Education

2000: University of Heidelberg Medical School, Heidelberg, Germany, MD

Internships

2002: Department of Anesthesia and Department of Thoracic Surgery ; University of Heidelberg Medical School and Thoraxklinik-Heidelberg GmbH, Heidelberg, Germany

Residency

2005: Indiana University School of Medicine, Indianapolis, IN, Internal Medicine

Fellowship

2008: Indiana University School of Medicine, Indianapolis, IN, Pulmonary and Critical Care Medicine

Awards & Recognition

2021: Chair, American Thoracic Society Pulmonary Circulation Assembly
2017: Program Committee Chair, American Thoracic Society Pulmonary Circulation Assembly
2017: Outstanding Postdoc Mentor Award, Indiana University School of Medicine
2015: Catherine and Lowe Berger and Pauline L. Ford Investigator of Pulmonary Medicine, Indiana University, Department of Medicine
2015: Outstanding Young Investigator, Indiana University, Department of Medicine
2012: Gilead Sciences Research Scholars in PAH Award, Gilead, Inc.
2012: First place winner, Translational Research Posters, Richard L. Roudebush VAMC Research Day
2011: ASPIRE Young Investigator Award in Pulmonary Vascular Disease Research, Pfizer, Inc.
2010: ATS/PHA/Pfizer Research Fellowship in PAH, ATS/Pulmonary Hypertension Association/Pfizer

Board Certification

Critical Care Medicine
Pulmonary Medicine
Internal Medicine

Professional Memberships

2017-Present: Alliance for Academic Medicine
2015-Present: American Heart Association
2013-Present: Pulmonary Vascular Research Institute
2009-Present: Pulmonary Hypertension Association
2007-Present: American Thoracic Society

Website Information

Lahm Lab

Ask a Question

Contact Information

Office: 877.225.5654

Locations

National Jewish Health Main Campus
1400 Jackson Street
Denver, CO 80206

Patient Ratings

Data Integrity Press Ganey Certified The Patient metric-rating score is an average of all responses to care provider related questions on our independent metric-rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.

Friendliness

4.9

Likelihood of recommending this provider

4.7

Provider explained things clearly

4.8

Provider showed concern

4.8

Provider included you in decisions

4.7

Amount of time spent with you

4.7

Confidence in your doctor

4.8

Spoke using clear language

4.9

Patient Comments

Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.

National Jewish Health Patient – April, 2024

Dr. Lahm and the entire pulmonary hypertension team is excellent at education, listening and recommended next steps. Follow up is amazing. I feel very 'taken care of'.
National Jewish Health Patient – March, 2024

My entire visit was conducted with a Dr without an exam. Nothing at all. A respiratory Dr would at least listen to my breathing and heart. Not sure he was prepared for my visit but was anxious to recommend more NJH services. I need the best care I can get not reasons to get additional services I do not need.
National Jewish Health Patient – March, 2024

Excellent experience very helpful to me.
National Jewish Health Patient – February, 2024

The provider was well prepared for my visit and was very easy to talk to -
National Jewish Health Patient – July, 2023

*Dr. Lahm was very professional, courteous, and friendly. I felt extremely confident and comfortable during my consultation with him.
National Jewish Health Patient – June, 2023

The fun thing about dealing with the brilliant doctors at NJ Health is that they take time to explain and share their analysis with you. Even with end-stage lung disease, I feel hopeful and have a firm grasp on this plan to give me the most beneficial experience on the rest of this path.